Home > Boards > US Listed > Medical - Equipment > Cytosorbents Corporation (CTSO)

I would say that you are incorrect on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biotech48 Member Profile
 
Followed By 2
Posts 581
Boards Moderated 0
Alias Born 03/22/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2022 4:32:05 PM
Leerink Partners Thinks Cytosorbents’ Stock is Going to Recover TipRanks - 1/20/2022 3:46:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/18/2022 4:32:30 PM
CytoSorbents jumps 1.86% on prelim FY21 and Q4 revenue above the consensus Seeking Alpha - 1/18/2022 7:35:44 AM
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue PR Newswire (US) - 1/18/2022 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2022 5:11:35 PM
Dawson James Remains a Buy on Cytosorbents (CTSO) TipRanks - 1/5/2022 4:10:04 AM
Dawson James Sticks to Their Buy Rating for Cytosorbents (CTSO) TipRanks - 1/5/2022 4:08:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/30/2021 5:29:04 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/30/2021 5:27:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2021 9:01:13 AM
CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular PR Newswire (US) - 12/21/2021 7:05:00 AM
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) PR Newswire (US) - 12/20/2021 7:10:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/13/2021 5:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2021 9:06:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/26/2021 6:11:44 PM
CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference PR Newswire (US) - 11/15/2021 4:30:00 PM
Cytosorbents EPS misses by $0.03, beats on revenue Seeking Alpha - 11/4/2021 4:29:11 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2021 4:15:41 PM
CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results PR Newswire (US) - 11/4/2021 4:15:00 PM
Cytosorbents Q3 2021 Earnings Preview Seeking Alpha - 11/3/2021 5:35:41 PM
CytoSorbents Comments on REMOVE Study Presentation PR Newswire (US) - 10/20/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2021 6:26:17 AM
First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery PR Newswire (US) - 10/14/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2021 7:01:40 AM
biotech48   Monday, 02/19/18 07:47:36 PM
Re: pearsby09 post# 11054
Post # of 27006 
I would say that you are incorrect on every point that you have made. There probably are thousands of physicians that have adopted the beads,not dozens, there have been over 40,000 treatments so far and counting. I seriously doubt that Dr. Chan considers these meetings as vacations. A huge number are across the river from New Jersey HQ into New York. Again, share price has not been a straight line $7.50 for 8 years. Look at the chart and you will see 8 years ago as mostly, $4, $5 and $6, what you have posted is extremely deceptive. Also, it does not take perfect timing to make money in CTSO, you could have bought for under $4.00 easily 6 months ago. These opportunities come up often. You could have bought in at $7 on February 9th and be up 9% in a week.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences